Effect of intraduodenal taurodeoxycholate and L-phenylalanine on pancreatic secretion and on gastroenteropancreatic peptide release in man.
Intraduodenally applied bile salts and essential amino acids are known to stimulate exocrine pancreatic secretion. There are contradictory reports, however, about an interaction of both stimuli with respect to pancreatic function. The intention of the study was to compare the effects of equimolar amounts of taurodeoxycholate and L-phenylalanine used singularly and combined on pancreatic secretion and on gastroenteropancreatic peptide release. In 12 healthy subjects, 0.8 mmol of Na-taurodeoxycholate (410 mg) and L-phenylalanine (130 mg) were separately and combined applied into the duodenum in a randomized order. Volume, bicarbonate, trypsin, lipase, and amylase secretion as well as cholecystokinin, pancreatic polypeptide, and somatostatin plasma levels were measured. Volume and bicarbonate secretion was significantly enhanced by taurodeoxycholate. The effect was stronger compared to L-phenylalanine. The increase of enzyme secretion was comparable. After combined application, the ecbolic effect was insignificantly smaller, whereas the hydrokinetic effect was between those of the single stimuli. Plasma levels of cholecystokinin, pancreatic polypeptide, and somatostatin rose concomitantly with the pancreatic response. On an equimolar basis taurodeoxycholate results in a stronger hydrokinetic effect than L-phenylalanine. Their ecbolic effects, however, are comparable. In addition to cholinergic mechanisms, as indicated by the PP release observed, cholecystokinin may also act as a mediator. In combined application, the stimuli interfere with each other. Somatostatin and pancreatic polypeptide are not responsible for this mutual inhibition.
Riepl
R L
RL
Medizinische Klinik, Klinikum Innenstadt, University of Munich, Germany.
Fiedler
F
F
Ernstberger
M
M
Teufel
J
J
Lehnert
P
P
D000681:Amylases / Q000378:metabolism; D001639:Bicarbonates / Q000378:metabolism; D002766:Cholecystokinin / Q000378:metabolism; D004386:Duodenum / Q000502:physiology*; D004750:Enteral Nutrition; D005768:Gastrointestinal Hormones / Q000097:blood / Q000378:metabolism*; D006801:Humans; D008049:Lipase / Q000378:metabolism; D010179:Pancreas / Q000187:drug effects / Q000201:enzymology / Q000378:metabolism*; D010191:Pancreatic Polypeptide / Q000097:blood / Q000378:metabolism; D010649:Phenylalanine / Q000008:administration & dosage / Q000494:pharmacology*; D012016:Reference Values; D013004:Somatostatin / Q000097:blood / Q000378:metabolism; D013657:Taurodeoxycholic Acid / Q000008:administration & dosage / Q000494:pharmacology*; D014357:Trypsin / Q000378:metabolism
D001639:Bicarbonates; D005768:Gastrointestinal Hormones; D010649:Phenylalanine; D013004:Somatostatin; D013657:Taurodeoxycholic Acid; D010191:Pancreatic Polypeptide; D002766:Cholecystokinin; D008049:Lipase; D000681:Amylases; D014357:Trypsin